Magle Chemoswed Holding AB (FRA:52X) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:52X Magle Chemoswed Holding AB FRA:52X
41 GF Score
Price €0.08
GF Value €1.81
! 6 Warning Signs
View Full Analysis

What is Magle Chemoswed Holding AB FFO per Share?

FFO per Share only applies to REITs.

FRA:52X
41GF Score
Magle Chemoswed Holding AB FRA:52X
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Magle Chemoswed Holding AB (FRA:52X) Overvalued in 2026?

Based on GuruFocus' analysis, Magle Chemoswed Holding AB stock appears to be undervalued. The current stock price of €0.08 is trading 95.6% below its estimated GF Value™ of €1.81.

Key valuation signals for FRA:52X:

  • FFO per Share:
  • GF Value™: €1.81 vs. price of €0.08 (95.6% below fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the FRA:52X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Magle Chemoswed Holding AB Business Description

Other Exchanges MAGLE:Sweden52X:Germany
Address Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
41GF Score

Get the complete analysis for FRA:52X

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.08
Price
€1.81
GF Value